[1]Scott,WilliamJ.;Hentemann,MartinF.;Rowley,R.Bruce;Bull,CathyO.;Jenkins,Susan;Bullion,AnnM.;Johnson,Jeffrey;Redman,Anikó;Robbins,ArthurH.;Esler,William;Fracasso,R.Paul;Garrison,Timothy;Hamilton,Mark;Michels,Martin;Wood,JillE.;Wilkie,DeanP.;Xiao,Hong;Levy,Joan;Stasik,Enrico;Liu,Ningshu;Schaefer,Martina;Brands,Michael;Lefranc,Julien[ChemMedChem,2016,p.1517-1530]
Title: Knight ZA, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125(4):733-47.
Title: Niedermeier M, et al. Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood. 2009 May 28;113(22):5549-57.
Title: Cheng CK, et al. Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12722-7.
